WHO will resume its trial of hydroxychloroquine for Coronavirus

World Health Organization Director-general, Tedros Adhanom Ghebreyesus said that WHO will resume its trial of hydroxychloroquine for potential use against the coronavirus,  after those running the study briefly stopped giving it to new patients over health concerns. Talking at an online media preparation he said that WHO specialists had educated



the continuation regarding all preliminaries including hydroxychloroquine. 

The U.N. organization a month ago stopped its enormous investigation of HCQ medicines against COVID-19 in which recently enlisted patients were getting the counter malarial medication because of fears of expanded passing rates and sporadic pulses.